|Daily Range||$289.76 - $296.00|
|52-Week Range||$194.66 - $358.89|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||2,070,292|
|Current FY EPS||$11.29|
How do you think BIIB
will perform against the market?
Top BIIB Bull/Bear Pitches
Submitted September 7, 2011
The clear leader in the independent biotechs is NOT likely to stay independent for long. I expect a buyout by Roche or even Pfizer or Merck in the next 6 months.
News & Commentary
Biogen Idec (BIIB) Description
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/